Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Placebo-Controlled, Double-Blind, Dose-Ranging (35mg/Day or 70 mg/Day), Randomized, Study of Cutaneous Dihydrotestosterone (DHT)-Gel (0.7% Hydroalcoholic Gel) in Older Hypogonadal Males Ages 55-80 Years: Effect on Body Composition, Libido, and Physical and Sexual Functioning

NCT00163566 is registered in ClinicalTrials.gov with ASCEND Therapeutics as lead sponsor.

NCT NCT00163566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00163566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Placebo-Controlled, Double-Blind, Dose-Ranging (35mg/Day or 70 mg/Day), Randomized, Study of Cutaneous Dihydrotestosterone (DHT)-Gel (0.7% Hydroalcoholic Gel) in Older Hypogonadal Males Ages 55-80 Years: Effect on Body Composition, Libido, and Physical and Sexual Functioning
Lead sponsor
ASCEND Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2004
Completion date
September 25, 2006
Enrollment
128 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadism, late onset hypogonadism, low testosterone